315 related articles for article (PubMed ID: 25692955)
1. Differential expression and regulation of Klotho by paricalcitol in the kidney, parathyroid, and aorta of uremic rats.
Ritter CS; Zhang S; Delmez J; Finch JL; Slatopolsky E
Kidney Int; 2015 Jun; 87(6):1141-52. PubMed ID: 25692955
[TBL] [Abstract][Full Text] [Related]
2. The vascular secret of Klotho.
Lewin E; Olgaard K
Kidney Int; 2015 Jun; 87(6):1089-91. PubMed ID: 26024025
[TBL] [Abstract][Full Text] [Related]
3. Increased parathyroid expression of klotho in uremic rats.
Hofman-Bang J; Martuseviciene G; Santini MA; Olgaard K; Lewin E
Kidney Int; 2010 Dec; 78(11):1119-27. PubMed ID: 20631679
[TBL] [Abstract][Full Text] [Related]
4. Paricalcitol and cinacalcet have disparate actions on parathyroid oxyphil cell content in patients with chronic kidney disease.
Ritter C; Miller B; Coyne DW; Gupta D; Zheng S; Brown AJ; Slatopolsky E
Kidney Int; 2017 Nov; 92(5):1217-1222. PubMed ID: 28750928
[TBL] [Abstract][Full Text] [Related]
5. KLOTHO methylation is linked to uremic toxins and chronic kidney disease.
Young GH; Wu VC
Kidney Int; 2012 Apr; 81(7):611-2. PubMed ID: 22419041
[TBL] [Abstract][Full Text] [Related]
6. Effect of paricalcitol and cinacalcet on serum phosphate, FGF-23, and bone in rats with chronic kidney disease.
Finch JL; Tokumoto M; Nakamura H; Yao W; Shahnazari M; Lane N; Slatopolsky E
Am J Physiol Renal Physiol; 2010 Jun; 298(6):F1315-22. PubMed ID: 20200094
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the effects of novel vitamin D receptor analog VS-105 and paricalcitol on chronic kidney disease-mineral bone disorder in an experimental model of chronic kidney disease.
Fujii H; Yonekura Y; Nakai K; Kono K; Goto S; Nishi S
J Steroid Biochem Mol Biol; 2017 Mar; 167():55-60. PubMed ID: 27818277
[TBL] [Abstract][Full Text] [Related]
8. Vitamin D Attenuates Endothelial Dysfunction in Uremic Rats and Maintains Human Endothelial Stability.
Vila Cuenca M; Ferrantelli E; Meinster E; Pouw SM; Kovačević I; de Menezes RX; Niessen HW; Beelen RHJ; Hordijk PL; Vervloet MG
J Am Heart Assoc; 2018 Sep; 7(17):e008776. PubMed ID: 30371149
[TBL] [Abstract][Full Text] [Related]
9. Parathyroid Klotho and FGF-receptor 1 expression decline with renal function in hyperparathyroid patients with chronic kidney disease and kidney transplant recipients.
Krajisnik T; Olauson H; Mirza MA; Hellman P; Akerström G; Westin G; Larsson TE; Björklund P
Kidney Int; 2010 Nov; 78(10):1024-32. PubMed ID: 20686451
[TBL] [Abstract][Full Text] [Related]
10. Differential effects of vitamin D receptor activators on aortic calcification and pulse wave velocity in uraemic rats.
Noonan W; Koch K; Nakane M; Ma J; Dixon D; Bolin A; Reinhart G
Nephrol Dial Transplant; 2008 Dec; 23(12):3824-30. PubMed ID: 18644798
[TBL] [Abstract][Full Text] [Related]
11. Differential effects of vitamin D receptor activators on vascular calcification in uremic rats.
Mizobuchi M; Finch JL; Martin DR; Slatopolsky E
Kidney Int; 2007 Sep; 72(6):709-15. PubMed ID: 17597697
[TBL] [Abstract][Full Text] [Related]
12. Vitamin D receptor agonist VS-105 directly modulates parathyroid hormone expression in human parathyroid cells and in 5/6 nephrectomized rats.
Sawada K; Wu-Wong JR; Chen YW; Wessale JL; Kanai G; Kakuta T; Fukagawa M
J Steroid Biochem Mol Biol; 2017 Mar; 167():48-54. PubMed ID: 27989797
[TBL] [Abstract][Full Text] [Related]
13. Depressed expression of Klotho and FGF receptor 1 in hyperplastic parathyroid glands from uremic patients.
Komaba H; Goto S; Fujii H; Hamada Y; Kobayashi A; Shibuya K; Tominaga Y; Otsuki N; Nibu K; Nakagawa K; Tsugawa N; Okano T; Kitazawa R; Fukagawa M; Kita T
Kidney Int; 2010 Feb; 77(3):232-8. PubMed ID: 19890272
[TBL] [Abstract][Full Text] [Related]
14. A correlation between decreased parathyroid α-Klotho and fibroblast growth factor receptor 1 expression with pathological category and parathyroid gland volume in dialysis patients.
Yan J; Jingbo C; Wang D; Xie S; Yuan L; Zhong X; Hao L
Int Urol Nephrol; 2015 Apr; 47(4):701-6. PubMed ID: 25749987
[TBL] [Abstract][Full Text] [Related]
15. Vitamin D receptor agonists increase klotho and osteopontin while decreasing aortic calcification in mice with chronic kidney disease fed a high phosphate diet.
Lau WL; Leaf EM; Hu MC; Takeno MM; Kuro-o M; Moe OW; Giachelli CM
Kidney Int; 2012 Dec; 82(12):1261-70. PubMed ID: 22932118
[TBL] [Abstract][Full Text] [Related]
16. Dual-specificity phosphatases are implicated in severe hyperplasia and lack of response to FGF23 of uremic parathyroid glands from rats.
Román-García P; Carrillo-López N; Naves-Díaz M; Rodríguez I; Ortiz A; Cannata-Andía JB
Endocrinology; 2012 Apr; 153(4):1627-37. PubMed ID: 22334717
[TBL] [Abstract][Full Text] [Related]
17. Effect of Paricalcitol on FGF-23 and Klotho in Kidney Transplant Recipients.
Donate-Correa J; Henríquez-Palop F; Martín-Núñez E; Pérez-Delgado N; Muros-de-Fuentes M; Mora-Fernández C; Navarro-González JF
Transplantation; 2016 Nov; 100(11):2432-2438. PubMed ID: 27467536
[TBL] [Abstract][Full Text] [Related]
18. Cardiac effect of vitamin D receptor modulators in uremic rats.
Mizobuchi M; Ogata H; Yamazaki-Nakazawa A; Hosaka N; Kondo F; Koiwa F; Kinugasa E; Shibata T
J Steroid Biochem Mol Biol; 2016 Oct; 163():20-7. PubMed ID: 27072785
[TBL] [Abstract][Full Text] [Related]
19. Sevelamer hydrochloride attenuates kidney and cardiovascular calcifications in long-term experimental uremia.
Cozzolino M; Staniforth ME; Liapis H; Finch J; Burke SK; Dusso AS; Slatopolsky E
Kidney Int; 2003 Nov; 64(5):1653-61. PubMed ID: 14531797
[TBL] [Abstract][Full Text] [Related]
20. Decreased calcium-sensing receptor expression in hyperplastic parathyroid glands of uremic rats: role of dietary phosphate.
Brown AJ; Ritter CS; Finch JL; Slatopolsky EA
Kidney Int; 1999 Apr; 55(4):1284-92. PubMed ID: 10200992
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]